GHK-CU demonstrates anti-inflammatory properties, helping reduce chronic inflammationa key driver of aging and age-related diseaseswhile supporting immune balance
BPC-157 appears to act at the gene expression level, potentially influencing actin production, whereas TB-500 is thought to interact more directly as an actin-binding protein
BPC-157 does not cause withdrawal symptoms or receptor dependence
Th17 cells, producing IL-17, IL-21, and IL-22, drive local inflammation, recruit neutrophils, and stimulate fibroblasts and epithelial cells, contributing to tissue damage
Product Name: FOXO4-DRI 10mg Catalogue Number: FOX-023 Purity: 98% Form: Lyophilised Solid Usage and Storage: FOXO4-DRI is supplied as a lyophilised solid to ensure maximum stability and ease of use in research environments
Conserve sus productos con GHK-Cu protegidos de la luz y del calor excesivo